PubMed HealthSearch

PubMed · 760446

Heparin therapy: a randomized prospective study.

Abstract

Eighty patients were assigned randomly either to continuous or to intermittent heparin therapy, with control by the Lee-White Clotting Time (LWCT). Major bleeding complications occurred in 7.5 per cent and minor complications in 18 per cent of the entire group. The incidence of major bleeding complications in the continuous group (5 per cent) did not differ significantly from the incidence in the intermittent group (10 per cent). In contrast, bleeding complications were significantly more frequent in patients with soft-tissue trauma due to such procedures as thoracenteses and cut-downs, vascular damage due to other causes, and LWCTs over 35 minutes for 2 consecutive days. The incidence of bleeding complications appear to be the same in patients receiving intermittent as in those receiving continuous heparin therapy. Thoracenteses, cut-downs, and other forms of soft-tissue injury predispose to bleeding complications while laboratory monitoring with the LWCT may help to reduce bleeding complications.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

J R Wilson, J Lampman. 1979. Heparin therapy: a randomized prospective study.. https://doi.org/10.1016/0002-8703(79)90349-1

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Is there an effective pharmacological treatment in the prevention of vasovagal syncope?

Many studies have claimed successful pharmacological prevention of vasovagal syncope in open formats with a wide variety of drugs. However, when therapy has been subjected to clinical trial to date no drug has shown any real benefit but it is necessary to add that the means of assessment leave much to be desired. These are repeat tilt testing, reported symptoms, analysis of syncopal burden in a population and time to syncopal recurrence. The disadvantages of any parameter derived from tilt testing is that its reproducibility is open to question and other aspects such as tilt duration before syncope have been inadequately investigated. With respect to symptom recurrence there are limitations because of the well known occurrence of vasovagal syncope in clusters and the long trial time that it is necessary because of relatively infrequent attacks. Furthermore, there is a placebo effect of the investigation of syncope which may delay the first recurrence. The first large trial is now underway and it is hoped that it may offer a method of prevention of vasovagal syncope which is both effective and acceptable.

Drug Evaluation